144 results
Page 3 of 8
8-K
EX-99.1
9i1eyv
24 May 22
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
ppnie 7bdy
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
EX-10.1
xgam0oaftzkuj7oye
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
k7hca5e9ns8c r7
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
8-K
EX-1.1
wumxm7d8x ftksa5lb52
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
8-K
EX-99.1
7gpvh2k2
30 Mar 22
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
4:19pm
8-K
EX-10.1
v4baf52pdcopv7b2
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
EX-10.1
gl14 n9tv10m
11 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
zgek0kk730 o01
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-1.1
if3ac7k2r
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
qvzbbi9i
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
pbmac
10 Jan 22
Prospectus supplement for primary offering
8:00am